Clinical Evaluation of Yervoy in Combination With Adoptive T Cell Transfer for Metastatic Melanoma Patients

Clinical trial NCT01988077 · TERMINATED

Trial details

NCT number: NCT01988077
Sponsor: Sheba Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

A Combination of Adoptive T Cell Therapy and Ipilimumab Could Increase the Proportion of CR Patients, and Durability of Response

Start date: 2013-10-01
Primary completion: 2016-05-20
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.